These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18392554)

  • 1. Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism.
    Martins R; Morais A; Dias A; Soares I; Rolão C; Ducla-Soares JL; Braga L; Seixas T; Nunes B; Olim G; Romão L; Lavinha J; Faustino P
    J Hum Genet; 2008; 53(6):524-528. PubMed ID: 18392554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of UGT1A1 promoter polymorphism, α-thalassemia and β
    Batista JVGF; Arcanjo GS; Batista THC; Sobreira MJ; Santana RM; Domingos IF; Hatzlhofer BL; Falcão DA; Pereira-Martins DA; Oliveira JM; Araujo AS; Laranjeira LPM; Medeiros FS; Albuquerque FP; Albuquerque DM; Santos MN; Hazin MF; Dos Anjos AC; Costa FF; Araujo AS; Lucena-Araujo AR; Bezerra MA
    Ann Hematol; 2021 Apr; 100(4):903-911. PubMed ID: 33523291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease.
    Vasavda N; Menzel S; Kondaveeti S; Maytham E; Awogbade M; Bannister S; Cunningham J; Eichholz A; Daniel Y; Okpala I; Fulford T; Thein SL
    Br J Haematol; 2007 Jul; 138(2):263-70. PubMed ID: 17593033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia.
    Chaar V; Kéclard L; Diara JP; Leturdu C; Elion J; Krishnamoorthy R; Clayton J; Romana M
    Haematologica; 2005 Feb; 90(2):188-99. PubMed ID: 15710570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia.
    Chaar V; Kéclard L; Etienne-Julan M; Diara JP; Elion J; Krishnamoorthy R; Romana M
    Am J Hematol; 2006 May; 81(5):377-9. PubMed ID: 16628735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
    AlFadhli S; Al-Jafer H; Hadi M; Al-Mutairi M; Nizam R
    PLoS One; 2013; 8(10):e77681. PubMed ID: 24204915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UGT1A1 promoter polymorphism associated with serum bilirubin level in Saudi patients with sickle cell disease.
    Hamad Z; Aljedai A; Halwani R; AlSultan A
    Ann Saudi Med; 2013; 33(4):372-6. PubMed ID: 24060717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia.
    Passon RG; Howard TA; Zimmerman SA; Schultz WH; Ware RE
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):448-51. PubMed ID: 11878580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene.
    Chaouch L; Talbi E; Moumni I; Ben Chaabene A; Kalai M; Chaouachi D; Mallouli F; Ghanem A; Abbes S
    Dis Markers; 2013; 35(2):67-72. PubMed ID: 24167350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?
    de Azevedo LA; Bonazzoni J; Wagner SC; Farias MG; Bittar CM; Daudt L; de Castro SM
    Mol Diagn Ther; 2017 Aug; 21(4):437-442. PubMed ID: 28567595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.
    Olatunya OS; Albuquerque DM; Akanbi GO; Aduayi OS; Taiwo AB; Faboya OA; Kayode TS; Leonardo DP; Adekile A; Costa FF
    BMC Med Genet; 2019 Oct; 20(1):160. PubMed ID: 31619193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UGT1A1 (TA)
    Joly P; Renoux C; Lacan P; Bertrand Y; Cannas G; Garnier N; Cuzzubbo D; Kebaïli K; Renard C; Gauthier A; Pialoux V; Martin C; Romana M; Connes P
    Eur J Haematol; 2017 Mar; 98(3):296-301. PubMed ID: 27981643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.
    Carpenter SL; Lieff S; Howard TA; Eggleston B; Ware RE
    Am J Hematol; 2008 Oct; 83(10):800-3. PubMed ID: 18756540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
    Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
    Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood.
    Grant DJ; Hall IJ; Eastmond DA; Jones IM; Bell DA
    Mutat Res; 2004 May; 560(1):1-10. PubMed ID: 15099818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of UGT1A1 promoter polymorphism on bilirubin response to hydroxyurea therapy in hemoglobinopathies.
    Italia KY; Jijina FF; Jain D; Merchant R; Nadkarni AH; Mukherjee M; Ghosh K; Colah RB
    Clin Biochem; 2010 Nov; 43(16-17):1329-32. PubMed ID: 20709051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.
    Fertrin KY; Melo MB; Assis AM; Saad ST; Costa FF
    Clin Genet; 2003 Aug; 64(2):160-2. PubMed ID: 12859413
    [No Abstract]   [Full Text] [Related]  

  • 18. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations.
    Lampe JW; Bigler J; Horner NK; Potter JD
    Pharmacogenetics; 1999 Jun; 9(3):341-9. PubMed ID: 10471066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of variant UDP-glucuronosyltransferase 1A1 gene, glucose-6-phosphate dehydrogenase deficiency and thalassemia on cholelithiasis.
    Huang YY; Huang CS; Yang SS; Lin MS; Huang MJ; Huang CS
    World J Gastroenterol; 2005 Sep; 11(36):5710-3. PubMed ID: 16237771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the A(TA)(n)TAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease.
    Kalotychou V; Antonatou K; Tzanetea R; Terpos E; Loukopoulos D; Rombos Y
    Blood Cells Mol Dis; 2003; 31(1):38-42. PubMed ID: 12850481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.